Central neurocytomas in children: Clinicopathologic features and long-term surgical outcomes.
Abstract
[PURPOSE] Pediatric central neurocytomas (PCNs) is an extremely rare entity, and very few reports have exclusively focused on the clinicopathologic features and surgical outcomes of PCNs.
[METHODS] This study was undertaken to elucidate the clinical and pathological characteristics and long-term surgical outcomes of PCNs.
[RESULTS] Fourteen consecutive patients with pathologically verified PCNs were identified, including 9 girls and 5 boys, with a mean age of 15.2 ± 3.9 years (range 3-18 years). Children tended to present with symptoms of increased intracranial pressure (ICP) (p = 0.003), an acute clinical course (p = 0.044), and a shorter duration of symptoms (p = 0.019) than their adult counterparts. Surgery was performed under the guidance of a neuronavigation system and intraoperative ultrasound; gross total resection (GTR) was achieved in 12 patients (85.7%), and subtotal resection (STR) was achieved in two patients (14.3%). One child received adjuvant radiotherapy (RT) owing to the atypical features of the lesion. During a mean follow-up of 90.2 ± 37.0 months (range 42-156 months), one patient (7.1%) with atypical features experienced lesion relapse 2 years after surgery and received RT, and the symptoms of all children were relieved.
[CONCLUSION] Surgery can benefit children with CNs and ensure relatively long-term progression-free survival. RT can be administered to patients with residual or relapsed lesions.
[METHODS] This study was undertaken to elucidate the clinical and pathological characteristics and long-term surgical outcomes of PCNs.
[RESULTS] Fourteen consecutive patients with pathologically verified PCNs were identified, including 9 girls and 5 boys, with a mean age of 15.2 ± 3.9 years (range 3-18 years). Children tended to present with symptoms of increased intracranial pressure (ICP) (p = 0.003), an acute clinical course (p = 0.044), and a shorter duration of symptoms (p = 0.019) than their adult counterparts. Surgery was performed under the guidance of a neuronavigation system and intraoperative ultrasound; gross total resection (GTR) was achieved in 12 patients (85.7%), and subtotal resection (STR) was achieved in two patients (14.3%). One child received adjuvant radiotherapy (RT) owing to the atypical features of the lesion. During a mean follow-up of 90.2 ± 37.0 months (range 42-156 months), one patient (7.1%) with atypical features experienced lesion relapse 2 years after surgery and received RT, and the symptoms of all children were relieved.
[CONCLUSION] Surgery can benefit children with CNs and ensure relatively long-term progression-free survival. RT can be administered to patients with residual or relapsed lesions.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 합병증 | intracranial
|
scispacy | 1 | ||
| 합병증 | lesions
|
scispacy | 1 | ||
| 약물 | PCNs
→ Pediatric central neurocytomas
|
scispacy | 1 | ||
| 약물 | STR
→ subtotal resection
|
scispacy | 1 | ||
| 질환 | Central neurocytomas
|
C0206719
Central Neurocytoma
|
scispacy | 1 | |
| 질환 | neurocytomas
|
C1622510
Neurocytoma
|
scispacy | 1 | |
| 질환 | CNs
|
scispacy | 1 | ||
| 기타 | children
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 |
MeSH Terms
Adult; Male; Female; Humans; Child; Child, Preschool; Adolescent; Neurocytoma; Brain Neoplasms; Radiotherapy, Adjuvant; Progression-Free Survival; Retrospective Studies; Treatment Outcome